Cystoid Macular Edema Clinical Trial
Official title:
Incidence and Risk Factors for Cystoid Macular Edema After Primary Vitrectomy With Gas Tamponade for Rhegmatogenous Retinal Detachment: a National Study Group
To investigate the incidence of cystoid macular edema in eyes with primary rhegmatogenous retinal detachment successfully treated with vitrectomy with gas tamponade, and to evaluate the clinical variables associated with its development.
this is an observational, retrospective, multicentre study. The study is based on the retrospective collection of clinical data from patients undergoing gas tamponade vitrectomy for rhegmatogenous retinal detachment. The collection of such data by the investigators will take place at each participating center anonymously. demographics, systemic, and preoperative, intraoperative and post-operative data will be collected The sample size was calculated to obtain approximately 200 patients with cystoid macular edema. Since cystoid macular edema has been detected in 13% of patients after retinal detachment gas vitrectomy, and assuming that this event can occur between 10% and 15% of cases, the study will include at least 2000 cases. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00508040 -
Evaluation of Birdshot Retine Choroidopathy Treatment by Either Steroid or Interferon alpha2a
|
Phase 2 | |
| Terminated |
NCT00114062 -
Study to Treat Uveitis Associated Macular Edema
|
Phase 2 | |
| Completed |
NCT03025945 -
Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3% Versus Placebo
|
N/A | |
| Completed |
NCT01978015 -
Blood-aqueous Barrier Changes After the Use of Timolol and Prostaglandin Analogues Fixed Combination in Pseudophakic Patients With POAG
|
Phase 4 | |
| Recruiting |
NCT05158699 -
Effectiveness of Periocular Drug Injection in CATaract Surgery
|
Phase 3 | |
| Withdrawn |
NCT02598869 -
Posterior Subtenon Versus Intravitreal Injection of Triamcinolone Acetonide for Treatment of Uveitic Cystoid Macular Edema
|
Phase 4 | |
| Terminated |
NCT04527523 -
Descemet Membrane Endothelial Keratoplasty vs. Descemet's Stripping With Endothelial Keratoplasty vs. Descemet Stripping Only
|
||
| Completed |
NCT02294656 -
Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone Acetonide
|
Phase 1 | |
| Withdrawn |
NCT00406172 -
Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)
|
Phase 3 | |
| Not yet recruiting |
NCT04856670 -
Assessing Diabetes Mellitus on Cytokine Analysis and Macular Edema Following FLACS
|
||
| Completed |
NCT02609165 -
Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema
|
Phase 2 | |
| Withdrawn |
NCT00438243 -
Pilot Study of the Effect of Topical Bromfenac Ophthalmic Solution 0.09%in Patients With Acute Post-operative Cystoid Macular Edema.
|
Phase 2 | |
| Completed |
NCT00464581 -
Lucentis for Treatment of Macular Edema
|
N/A | |
| Active, not recruiting |
NCT03465124 -
Evaluation of Central Macular Thickness in Femtosecond Laser-assisted Cataract Surgery
|
N/A | |
| Recruiting |
NCT02486484 -
Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection
|
Phase 2 | |
| Completed |
NCT00790803 -
Pegaptanib Therapy in Non-Infectious Uveitic Cystoid Macular Edema
|
N/A | |
| Recruiting |
NCT04225611 -
Therapeutic Contact Lens Drug Delivery System (TCL-DDS) in Patients With Recurrent Cystoid Macular Edema
|
Phase 1/Phase 2 | |
| Completed |
NCT05832996 -
Cool vs Room-temperature Artificial Tears
|
Phase 4 | |
| Completed |
NCT05615805 -
The Effect of Ocular Rinse Volume on Surface Irritation After Intravitreal Injections
|
N/A | |
| Completed |
NCT00494494 -
Effect of Nepafenac on Post-operative Macular Swelling Following Uncomplicated Cataract Surgery
|
Phase 4 |